A comprehensive view of immune system health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

ViiV Healthcare announces US FDA approval of Apretude injectable suspension, a long-acting treatment for HIV prevention; drug is approved for use in adults and adolescents at risk of sexually acquiring HIV
Published: December 20, 2021 by GlaxoSmithKline PLC
Kite, a Gilead Company, and Daiichi Sankyo announce first treatment center in Japan for administration of YESCARTA for relapsed or refractory large B-cell lymphomas; product is an immunotherapy that requires clinician training before it is administered
Published: December 16, 2021 by Gilead Sciences Inc.
Euromonitor estimates consumer health industry to grow 2.9% in 2021, projects modest growth between 2021-2025 as consumer behavior moves toward pre-pandemic norms; non-immunity categories should resume growth, and sports nutrition to also benefit
Published: December 15, 2021 by Euromonitor International Ltd.
Pfizer approves Pfizer's oral XELJANZ for treatment of active ankylosing spondylitis; drug offers alternative to drugs administered by injection or infusion
Published: December 15, 2021 by Pfizer Inc.
Pfizer enters agreement to acquire Arena Pharmaceuticals, a clinical-stage developer of therapies for immuno-inflammatory diseases, for about US$6.7B; Pfizer expects to finance the transaction with existing cash on hand
Published: December 14, 2021 by Pfizer Inc.

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count